The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2019 edition of the CPT coding manual. In addition, CMS has also made changes to Healthcare Common Procedure Coding System (HCPCS) codes.
Diagnostic Laboratory of Oklahoma (DLO) will be implementing these changes effective January 1, 2019. Overall, the changes for 2019 affect the way we bill some of our tests. These tests may also be included in panels or profiles. The below chart lists the tests affected and the appropriate CPT code changes.
|DLO Order Code||DLO Test Name||2018 CPT Coding||2019 CPT Coding|
|36168||Dihydrotestosterone (DHT), Free, Serum||80327||82642|
|91771||MYD88, Mutation Analysis||81479||81305|
|36164||DMPK DNA Test (DM1)||81401||81234|
|10247||Huntington Disease Mutation Analysis||81401||81271|
|14871||Huntington Disease Mutation Analysis (NY)||81401||81271|
|94372||QHerit™ Expanded Carrier Screen||81257, 81209, 81200, 81260, 81242, 81251, 81250, 81205, 81290, 81330, 81255, 81220, 81243, 81361, 81400 (x4), 81401 (x2), 81479||81443|
|91866||BRCAvantage®, Rearrangements||81213, 81479||81164|
|18041||SMA Carrier Screen||81401||81329|
|16869||SMA Diagnostic Test||81401||81329|
|90949||Prenatal Carrier Screen||81220, 81243, 81401||81220, 81243, 81329|
|93349||Prenatal Carrier Panel||81220, 81243, 81401||81220, 81243, 81329|
|92688||Liver Fibrosis, FibroTest-ActiTest Panel||[MAAA: 0001M] or 82172, 82247, 82977, 83010, 83883, 84460*||81596|
We appreciate your support and look forward to continuing to serve all of your laboratory needs. We at DLO will make every effort to assist you with the transition to the 2019 AMA CPT coding being used for our test offerings.
Note: The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.